Antibiotics help prevent MS relapses

Adding antibiotics to current multiple sclerosis (MS) treatment could help prevent relapses by halving the number of brain lesions formed by the condition, US researchers suggest.

Currently, patients with relapsing–remitting MS are prescribed interferon beta-1a, but many still experience relapses and may continue to develop new areas of damaged brain tissue, say the researchers.

For this latest study, the researchers examined 15 patients with relapsing remitting MS who had been taking interferon for at least six months and were experiencing symptoms and developing new brain lesions.

For four months, participants were given 100mg doxycycline daily in addition to interferon treatment.

They also underwent monthly neurological examinations and MRI brain scans to detect the formation of brain lesions.

At the end of the study, the researchers found that the combination treatment had resulted in fewer brain lesions, as visualised by the MRI scans.

The average number of brain lesions decreased from 8.8 per MRI scan to just four after antibiotic use was added to the treatment regime.

The participants also had reduced average scores on a scale designed to assess disability levels.

Using a scale ranging from 1.5 to 4.5 to measure increasing disability levels, the researchers found that antibiotic treatment reduced disability severity from 3.8 to 2.3.

During the study, one patient experienced a relapse and two experienced adverse effects, such as muscle pain and fatigue, because of the combination treatment.

sanjay.tanday@haymarket.com

View the study published in Archives of Neurology

Comment below and tell us what you think 

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Care home vaccination to begin as Scottish minister says Pfizer vaccine packs can be split up

Vaccination of care home residents against COVID-19 will start on 14 December in...

How will the COVID-19 vaccination programme get underway?

How will the COVID-19 vaccination programme get underway?

Following the MHRA's approval of Pfizer/BioNTech's COVID-19 jab the government has...

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

NHS must keep doctors who returned in pandemic as overseas supply dries up, says GMC

Doctors who rejoined the NHS workforce in the pandemic must be urged to stay to help...

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GPs unlikely to begin COVID-19 vaccination for 'at least two weeks', says BMA

GP practices are unlikely to receive stocks of COVID-19 vaccine 'for at least another...

JCVI confirms priority groups for COVID-19 vaccination

JCVI confirms priority groups for COVID-19 vaccination

The Joint Committee on Vaccination and Immunisation (JCVI) has published a final...

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

MHRA approves Pfizer/BioNTech jab paving way for COVID-19 vaccination to start

The MHRA has approved the Pfizer/BioNTech COVID-19 vaccine for use in the UK and...